2015 American Transplant Congress
Avoiding Futility in Simultaneous Liver-Kidney Transplantation (SLKT): Analysis of 331 Consecutively Listed Patients
Without well-established listing guidelines for SLKT, MELD prioritization of liver recipients with renal dysfunction potentially risks scarce renal allografts. We sought to evaluate short-term predictors…2015 American Transplant Congress
Weight Loss, But Not Weight Gain Is a Risk Factor for Graft Loss After Kidney Transplantation
Division of Nephrology, University of British Columbia, Vancouver, Canada.
Weight gain is common after kidney transplantation. In this analysis of n=92,688 adult 1st kidney transplant recipients with graft survival of ≥ 1 year between…2015 American Transplant Congress
Kidney Transplant Outcomes in Patients With Amyloidosis
Objective: Analyze kidney allograft outcomes in patients with kidney failure due to amyloidosis, and compare kidney transplant survival to patients with other causes of kidney…2015 American Transplant Congress
Attenuating Racial Disparities in Kidney Transplantation Through the Use of Potent Immunosuppression Regimens
Medical University of South Carolina, Charleston, SC.
African-American (AA) kidney transplant (KTX) recipients have higher rates of graft loss, which may be partially attributed to higher immunologic risk. The aim of this…2015 American Transplant Congress
Passive Administration of Antibodies to Cardiac Myosin Immediately Following Syngenic Cardiac Transplantation Result in Rejection
Surgery, Washington Univ Sch of Med, St. Louis, MO.
Introduction: Auto-immune responses to cardiac myosin, a heart specific protein has been proposed to be a target auto-antigen resulting in cardiac allograft vasculopathy following transplantation.…2015 American Transplant Congress
Long-Term Outcome of Liver Transplant Recipients (OLT) With Hepatitis C Recurrence (HCVR) Who Achieved Postoperative Sustained Virologic Response (SVR) After Combination Antiviral Therapy (Rx) With and Without the Use of Telaprevir (TVR): A Single Center Experience
Liver Institute, Methodist Dallas Medical Center, Dallas, TX.
Aim: Liver allografts of viremic OLT have a higher risk of failure. Timely intervention is necessary. However, long-term outcome reports, especially using newer agents, is…
- « Previous Page
- 1
- …
- 53
- 54
- 55